Published: 16 Dec 2022 979 views
This second call for proposals under phase II is directed toward proposals in the field of communicable diseases, with a particular focus on investigating underlying biological mechanisms and impacts on global health. Potential topics may include, but are not limited to, the following:?
Discovery research to identify new pathogens and their distribution in human populations?
New therapeutic approaches for communicable diseases?
Drug resistance biology and mechanism in infectious disease?
Host-parasite interactions?
New directions in vaccine research for infectious diseases?
New biomarkers for infectious disease detection, characterization and monitoring?
Vector-borne and zoonotic diseases, including the impact of climate change on zoonotic disease distribution?
New technology platforms for rapid detection of pathogens of pandemic importance?
Exclusions: SARS-CoV-2/COVID-19 research, studies, surveys, clinical trials and work primarily aimed at informing public health policy are NOT eligible for funding through this opportunity. However, the use of randomization in basic biomedical research studies is accepted.?
As part of Canada’s foreign affairs and development efforts, IDRC champions and funds research?and innovation?within?and alongside developing?regions?to?drive global change. Our head office is located in Ottawa, Canada, while five regional offices keep us close to our work. They are located in Montevideo, Uruguay; Nairobi, Kenya; Dakar, Senegal; Amman, Jordan; and New Delhi, India. IDRC is governed by a board of up to 14 governors, whose chairperson reports to Parliament through the Minister of International Development. IDRC was established by an act of Canada’s parl... continue reading
Application Deadline | 17 Jan 2023 |
Country to study | Canada |
Type | Contest |
Sponsor | International Development Research Centre (IDRC) |
Gender | Men and Women |
FUNDED BY
IDRC, the Israel Science Foundation, the Azrieli Foundation and the Canadian Institutes of Health Research
Six?grants worth up to CAD 1.4 million each
Sponsor(s)
Phase II of the Joint Canada–Israel Health Research Program is a collaboration of the Azrieli Foundation (AF), Canada’s International Development Research Center (IDRC), the Canadian Institutes of Health Research (CIHR), Institute of Infection and Immunity (III) and CIHR Centre for Research on Pandemic and Preparedness for Health Emergencies (CRPPHE), and the Israel Science Foundation (ISF).
Phase II of the Joint Canada-Israel Health Research Program seeks to support fundamental research at the cutting-edge of biomedical science and global health.
Proposals must be co-led by three independent investigators:
one from Canada, one from Israel and one from a low- or middle-income country.
Teams are required to establish knowledge mobilization plans.
This could include a range of activities that support research, training and exchange, while taking advantage of this funding opportunity to design a collaborative international research project.
More details
Further details on the call and detailed guidelines?for submission are published on?CIHR’s Funding Opportunity database.
Please consult the list of eligible low-and middle-income countries/territories.
Deadlines
In Canada
Registration: January 17, 2023 at 20:00 Ottawa time; Application: February 16, 2023 at 20:00 Ottawa time
In Israel
Registration: January 17, 2023 at 13:00 Jerusalem time; Application: February 15, 2023 at 13:00 Jerusalem time
For more details visit: IDRC website.